StockNews.AI
JNJ
StockNews.AI
34 days

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

1. JNJ declared a $1.30 cash dividend for Q3 2025. 2. Dividend payable on September 9, 2025, to eligible shareholders. 3. Strong emphasis on healthcare innovation noted in JNJ's strategy.

2m saved
Insight
Article

FAQ

Why Bullish?

Regular dividend payments indicate financial health and shareholder return. Historically, dividends positively influence stock prices, especially in established companies like JNJ.

How important is it?

The dividend reflects JNJ's commitment to returning value to shareholders, crucial amidst market uncertainties.

Why Long Term?

Dividend announcements foster investor confidence and long-term investment thesis. A consistent dividend can lead to increased share prices over time due to demand from dividend-focused investors.

Related Companies

- NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. More News From Johnson & Johnson

Related News